John G Ullman & Associates Inc. Buys 27,931 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

John G Ullman & Associates Inc. raised its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 93.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 57,916 shares of the company’s stock after acquiring an additional 27,931 shares during the period. John G Ullman & Associates Inc.’s holdings in GE HealthCare Technologies were worth $4,478,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the stock. Daiwa Securities Group Inc. grew its position in GE HealthCare Technologies by 4.6% in the fourth quarter. Daiwa Securities Group Inc. now owns 58,572 shares of the company’s stock valued at $4,529,000 after acquiring an additional 2,578 shares during the period. River Road Asset Management LLC grew its holdings in shares of GE HealthCare Technologies by 439.8% during the fourth quarter. River Road Asset Management LLC now owns 462,660 shares of the company’s stock worth $35,773,000 after purchasing an additional 376,958 shares during the last quarter. Archer Investment Corp grew its holdings in shares of GE HealthCare Technologies by 404.6% during the fourth quarter. Archer Investment Corp now owns 661 shares of the company’s stock worth $51,000 after purchasing an additional 530 shares during the last quarter. Rakuten Securities Inc. bought a new stake in shares of GE HealthCare Technologies during the fourth quarter worth $78,000. Finally, SVB Wealth LLC grew its holdings in shares of GE HealthCare Technologies by 7.5% during the fourth quarter. SVB Wealth LLC now owns 6,126 shares of the company’s stock worth $474,000 after purchasing an additional 425 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently commented on GEHC. Mizuho increased their target price on GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, April 11th. Evercore ISI upped their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research note on Thursday, April 4th. Argus increased their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. UBS Group raised GE HealthCare Technologies from a “sell” rating to a “neutral” rating and increased their target price for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Finally, Morgan Stanley increased their target price on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research note on Monday, February 12th. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $95.08.

GE HealthCare Technologies Stock Down 0.6 %

GEHC stock traded down $0.48 during mid-day trading on Friday, reaching $84.49. The company had a trading volume of 1,891,405 shares, compared to its average volume of 3,381,772. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83. The stock has a 50 day simple moving average of $88.67 and a two-hundred day simple moving average of $77.70. The company has a market capitalization of $38.56 billion, a price-to-earnings ratio of 28.14, a PEG ratio of 2.96 and a beta of 0.94. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The firm had revenue of $5.20 billion during the quarter, compared to the consensus estimate of $5.09 billion. During the same period last year, the company earned $1.31 earnings per share. The business’s revenue was up 5.3% compared to the same quarter last year. As a group, equities analysts predict that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a $0.03 dividend. The ex-dividend date is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. GE HealthCare Technologies’s payout ratio is 3.97%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.